Browse > Article
http://dx.doi.org/10.3345/kjp.2010.53.3.437

A case of steroid-induced psychosis in a child having nephrotic syndrome with toxic epidermal necrolysis  

Kim, Sae Yoon (Department of Pediatrics, Yeungnam University College of Medicine)
Lee, Jae Min (Department of Pediatrics, Yeungnam University College of Medicine)
Park, Yong Hoon (Department of Pediatrics, Yeungnam University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.53, no.3, 2010 , pp. 437-441 More about this Journal
Abstract
Toxic epidermal necrolysis (TEN) and Stevens Johnson syndrome (SJS) are rare, life-threatening mucocutaneous -diseases, usually attributable to drugs and infections. Corticosteroids have been used in the management of TEN for the last 30 years. This remains controversial and is still much debated. TEN can occur despite administration of high doses of systemic corticosteroids. The psychiatric side effects of corticosteroids can include headache, insomnia, depression, and mood disorders with or without psychotic episodes. Steroid-induced psychosis is dealt with by tapering or discontinuing the steroid; antipsychotics are also sometimes used. We report a case of an 11-year-old boy who was admitted with TEN. He had also been diagnosed as having nephrotic syndrome in the past. Remission was achieved through induction therapy and by maintaining the use of steroids. After a full-dose intravenous dexamethasone for TEN, he showed psychotic symptoms. We diagnosed him as having steroid-induced psychosis. We tapered the steroid use and initiated an atypical antipsychotic medication, olazapine and intravenous immunoglobulin (IV-IG). His symptoms dramatically improved and he was discharged.
Keywords
Nephrotic syndrome; Toxic epidermal necrolysis; Steroid-induced psychosis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R. Treatment of toxic epidermal necrolysis. Arch Dermatol 1987;123:1156-8   DOI   ScienceOn
2 Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, et al. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 2000;57:249-58   DOI   ScienceOn
3 Mukasa Y, Craven N. Management of toxic epidermal necrolysis and related syndromes. Postgrad Med J 2008;84:60-5   DOI   ScienceOn
4 Lauerma AI, Reitamo S, Maibach HI. Systemic hydrocortisone/cortisol induces allergic skin reactions in presensitized subjects. J Am Acad Dermatol 1991;24:182-5   DOI   ScienceOn
5 Schieveld JN, Lousberg R, Berghmans E, Smeets I, Leroy PL, Vos GD, et al. Pediatric illness severity measures predict delirium in a pediatric intensive care unit. Crit Care Med 2008;36:1933-6   DOI   ScienceOn
6 Kim DW, Jung DE, Koo JW. Steroid and enalapril therapypossible cause of toxic epidermal necrolysis. Korean J Pediatr 2006;49:332-6   DOI
7 Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol 2003;139:39-43   DOI   ScienceOn
8 Herg$\"{u}$ner S, Bilge I, Yavuz YA, Tüzün DU. Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone. Turk J Pediatr 2006;48:244-7   PUBMED
9 Benyamin R, Vallejo R, Kramer J, Rafeyan R. Corticosteroid induced psychosis in the pain management setting. Pain Physician 2008;11:917-20   PUBMED   ScienceOn
10 Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, et al. Treatment of toxic epidermal necrolysis with highdose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003;139:26-32   DOI   ScienceOn
11 Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85   DOI   ScienceOn
12 Clark LD, Bauer W, Cobb S. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Engl J Med 1952;246:205-16   DOI   PUBMED   ScienceOn
13 Soliday E, Grey S, Lande MB. Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics. 1999;104:e51   DOI   PUBMED   ScienceOn
14 Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7   DOI   ScienceOn
15 Schieveld JN, Leroy PL, van Os J, Nicolai J, Vos GD, Leentjens AF. Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med 2007;33:1033-40   DOI   ScienceOn
16 Werhli P, Viard I, Bullani R, Tschopp J, French LE. Death receptors in cutaneous in cutaneous biology and disease. J Invest Dermatol 2000;115:141-8   DOI   PUBMED   ScienceOn
17 Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol 1985;121:1548-9   DOI   ScienceOn
18 Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005;153:241-53   DOI   ScienceOn
19 Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, et al. Corticosteroid -induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001;42:461-6   DOI   ScienceOn
20 Lopez-Medrano F, Cervera R, Trejo O, Font J, Ingelmo M. Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level. Ann Rheum Dis 2002;61:562-3   DOI   ScienceOn